Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults

NCT00746798 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

West Nile Fever

Interventions

BIOLOGICAL: ChimeriVax-WN02 vaccine
BIOLOGICAL: ChimeriVax-WN02 vaccine
BIOLOGICAL: ChimeriVax-WN02 vaccine
BIOLOGICAL: Placebo

Sponsor

Sanofi Pasteur, a Sanofi Company